- Report
- August 2025
- 196 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 190 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 192 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- June 2025
- 400 Pages
Global
From €4448EUR$4,949USD£3,862GBP
- Report
- June 2025
- 92 Pages
Global
From €3500EUR$4,171USD£3,145GBP
- Report
- July 2025
- 150 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- August 2024
- 150 Pages
Global
From €3371EUR$3,750USD£2,926GBP
- Report
- May 2024
- 250 Pages
Global
From €4490EUR$4,995USD£3,897GBP
- Report
- September 2024
- 117 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- August 2025
- 150 Pages
Global
From €3018EUR$3,358USD£2,620GBP
€3551EUR$3,950USD£3,082GBP
The Synthetic Biomaterial market is a subset of the larger Biomaterials market, which encompasses materials used in medical and healthcare applications. Synthetic Biomaterials are man-made materials that are designed to interact with biological systems, such as the human body. These materials are used in a variety of medical applications, including implants, prosthetics, and drug delivery systems. Synthetic Biomaterials are designed to be biocompatible, meaning they are non-toxic and do not cause an immune response. They are also designed to be durable and long-lasting, allowing them to be used in a variety of medical applications.
Some companies in the Synthetic Biomaterial market include Corbion, PolyOne Corporation, Evonik Industries, Solvay, and BASF. Show Less Read more
